Raffaella Maria Gadaleta

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Raffaella Maria Gadaleta, Karel J. van Erpecum, Bas Oldenburg et al. · Gut · 2011 · 851 citations

Life Sciences, Immunology, Pharmacology +17

Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine

Raffaella Maria Gadaleta, Bas Oldenburg, Ellen C.L. Willemsen et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2011 · 186 citations · Full text

Life Sciences, Molecular Medicine, Cell Signaling +15

Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor

Raffaella Maria Gadaleta, Oihane García‐Irigoyen, Marica Cariello et al. · EBioMedicine · 2020 · 116 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease

Rian M. Nijmeijer, Raffaella Maria Gadaleta, Saskia W. C. van Mil et al. · PLoS ONE · 2011 · 114 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer

Luca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta et al. · Nature Genetics · 2017 · 90 citations

Medicine, Oncology, Pharmacology +17